What percentage of primary total hip replacement (THR) cases experience early acetabular cup loosening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Early Acetabular Cup Loosening in Total Hip Replacement

Early aseptic loosening of cementless monoblock acetabular components occurs in approximately 1.0% of primary total hip replacement cases 1.

Incidence and Timing

The best available data from a large retrospective analysis of 4,043 cementless hip devices (3,209 THAs and 834 HRAs) demonstrates that early acetabular component loosening has an incidence of 1.0%, with a mean time to revision of 1.2 years (range 0.0-5.4 years) 1. This represents a relatively rare but clinically significant complication that typically manifests within the first 1-2 years post-operatively.

Key Risk Factors for Early Loosening

The evidence identifies specific technical and anatomical factors that significantly increase the risk:

Acetabular Morphology

  • Dorr type A and C acetabular morphology are significantly associated with early loosening (P = 0.014) 1
  • These bone types present challenges for achieving adequate initial stability during implantation

Component Positioning Errors

  • More vertical cup positioning (increased inclination angle) is strongly associated with early loosening (P < 0.001) 1
  • Decreased anteversion also correlates with early failure (P = 0.001) 1
  • These positioning errors most likely reflect intraoperative challenges in obtaining sufficient primary stability

Important Negative Findings

  • Acetabular dysplasia does not associate with early loosening 1
  • Acetabular component type (specific implant design) does not significantly influence early loosening rates 1

Clinical Implications

The primary etiology of early acetabular loosening is surgical technique error rather than implant design or patient bone quality 1. Suboptimal cup positioning—particularly excessive vertical inclination and insufficient anteversion—reflects difficulties achieving adequate mechanical stability during surgery. This is especially problematic in Dorr type A (very dense, thick cortical bone with narrow canal) and type C (very poor quality bone) acetabular morphologies, which present opposite but equally challenging fixation scenarios.

Migration Patterns and Prediction

A comprehensive meta-analysis of 83 cohorts (2,328 cups) using radiostereometric analysis (RSA) provides additional context 2:

  • The majority of cup migration occurs within the first 6 months post-operatively
  • Mean pooled proximal migration at 6 months: 0.11 mm (95% CI 0.06-0.16)
  • No significant increase in migration between 6 months and 2 years (0.015 mm, 95% CI 0.000-0.030)
  • 36% of cohorts demonstrated mean proximal migration >0.2 mm at 2 years, which predicts risk of long-term loosening 2

Diagnostic Considerations

When evaluating suspected loosening in symptomatic patients, the 2023 ACR guidelines indicate 3:

  • MRI with metal artifact reduction (MAR) shows superior sensitivity (83%) and specificity (98%) for acetabular component loosening compared to radiographs (sensitivity 26%, specificity 100%)
  • CT with MAR demonstrates sensitivity of 84.85% for acetabular loosening with high specificity (95.4-96.9%) 3
  • SPECT/CT shows excellent performance with sensitivity 93%, specificity 97% for detecting loosening 3

Critical Pitfall to Avoid

The most important clinical takeaway is that early acetabular loosening is predominantly a technical failure. Surgeons must pay meticulous attention to achieving optimal cup positioning (avoiding excessive vertical inclination and ensuring adequate anteversion) and confirming adequate primary stability, particularly in challenging bone morphologies (Dorr A and C types). The 1.0% incidence represents preventable failures in most cases through improved surgical technique and intraoperative assessment of component stability.

References

3
Guideline

acr appropriateness criteria® imaging after total hip arthroplasty.

Journal of the American College of Radiology, 2023

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
In a patient who has had his tonsils and adenoids removed and now has difficulty swallowing solids, what is the appropriate evaluation and management?
In a patient with prior tonsillectomy and adenoidectomy who presents with solid‑food dysphagia, a non‑erythematous throat, and visible drainage, what is the next step in management?
What is the appropriate management of hypocalcemia in a trauma patient?
What is the appropriate treatment for early acetabular cup loosening after a primary total hip replacement?
Is N‑acetylcysteine (NAC) indicated for salicylate toxicity?
What is the appropriate evaluation and management of salty cravings in a patient receiving a glucagon‑like peptide‑1 (GLP‑1) receptor agonist?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.